GlobeNewswire Inc.··NaRapport Therapeutics to Unveil RAP-219 Phase 2 Data for Seizure Treatment
Rapport Therapeutics will present Phase 2a follow-up data for experimental seizure drug RAP-219 at neurology conference in April 2026.
RAPPprecision medicinephase 2 trial